Magnetic anchor technique assisting reduced-trocar VATS pulmonary lobectomy: prospective single-center randomized controlled clinical trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029676

Enrollment

Unknown

Registered

2020-02-09

Start date

2020-04-01

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodules

Interventions

experimental group:Magnetic anchor assisting VATS

control group:VATS

Eligibility

Sex/Gender

All

Age

15 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Benign and malignant pulmonary nodules, including pulmonary hamartoma, sclerosing hemangioma, lung cancer, etc; 2. Thoracoscopic lobectomy is required, agree to participate in this clinical trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Has serious comorbidities, cannot tolerate thoracoscopic surgery; 2. MBI > 28; 3. Hilar frozen caused by fusion of enlarged lymph nodes, difficult to operate under thoracoscopy; 4. Operation contraindications.

Design outcomes

Primary

Measure	Time frame
Safety;	—

Secondary

Measure	Time frame
Feasibility;	—

Countries

China

Contacts

Public ContactYong Zhang

The First Affiliated Hospital of Xi'anJiaotong University

zhangyongyang05@163.com+86 13201686108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 19, 2026